March 26, 2025 · Form 4 insider transaction
SUVRETTA CAPITAL MANAGEMENT, LLC bought 793,800 shares of BENITEC BIOPHARMA INC at $13.00 per share, a transaction worth $10.32M. The trade was recorded as open-market purchase and disclosed on an SEC Form 4, filed 2 days after the transaction.
Notes are included on Exhibit 99.1.; Notes are included on Exhibit 99.1.